Worms, Lasers, and Donuts

DENVER, Colo., Oct 22, 2025 (247marketnews.com)- As markets enter the final trading stretch of the day, investor attention is shifting to a mix of defense-tech disruptors, digital asset crossovers, and even a surprise move in doughnuts and diagnostics. These are the tickers to watch into the close and after-hours, with several under-the-radar names staging breakout narratives.

Forget steel. Kraig Biocraft Laboratories (OTCQB:KBLB) sixth production cycle of its BAM-1 Alpha recombinant spider silk technology may finally turn one of nature’s strongest materials into a scalable, industrial-grade armor solution.

  • Stronger than Kevlar by weight
  • Fully bioengineered using silkworms, solving spider farming limitations
  • Key military and protective gear applications: bulletproof vests, blast fabrics, and more

With global defense budgets ballooning, CEO Kim Thompson called the launch “exhilarating,” stating the company’s spider silk evolution now allows for “scalable production with no need for infrastructure changes.”

Applied DNA Sciences (NASDAQ:BNBX) stunned the market today with a $58 million private placement and a bold move into BNB digital asset treasury strategy, effectively positioning itself as one of the first biotech-digital asset hybrids on the NASDAQ.

  • Acquired 10,647 BNB tokens via OBNB trust
  • Purchased 4,908 additional BNB tokens (~$5.3M)
  • Announced $2.9M in annualized cost savings from streamlined operations

CIO Patrick Horsman sees BNB as a “next institutional-grade blockchain,” while CEO Clay Shorrock stressed the alignment of “resources with strategic priorities.”

NUBURU (NYSE:BURU) is flying higher into the close after detailing a defense JV with Maddox Defense and Nuburu Defense LLC. The joint venture will develop advanced drones for NATO allies, integrating:

  • Blue-laser systems (Nuburu’s specialty)
  • Modular 3D-printing assembly pods
  • The recently acquired Orbit operational resilience platform

JV aims to capture part of the $7–$10.3B NATO UAV market, with $100M annual revenue projected by 2028 from commercial drone sales.

JV formation is expected by December 15, 2025, with European operations governed under Italian law to maintain U.S. export compliance.

Krispy Kreme (NASDAQ:DNUT) is gaining traction, as analysts cite strong Halloween seasonal sales and potential international licensing updates in upcoming earnings. The company has:

  • Teased new partnerships with theme parks and entertainment venues
  • Seen surging demand in UK and Japanese markets
  • Focused on increasing hub-and-spoke distribution efficiencies

With Halloween among the company’s most profitable retail windows, DNUT may surprise on Q4 guidance, especially with new product SKUs and retail expansion.

iBio (NYSEAMERICAN:IBIO) is showing signs of life after weeks of low volume. While no new filings hit today, speculation is rising around:

  • Upcoming pipeline updates in its AI-discovered immunotherapy programs
  • Possible strategic partnerships or licensing agreements in Q4
  • Continued focus on plant-based biologic manufacturing platforms

With renewed retail interest in preclinical biotechs and recent news cycles favoring novel therapeutic production platforms, IBIO is on radar as a potential late-day runner.

INVO Bioscience (NASDAQ:INVO) is aiming to decentralize and democratize fertility treatments with its INVOcell device, an in-vivo alternative to traditional IVF. While quiet today, the broader narrative is bullish:

  • Rising demand for affordable, accessible fertility care globally
  • Recently expanded its U.S. clinic footprint
  • Eyes growth in India, Latin America, and Africa where IVF access is limited

For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit www.kraiglabs.com

Please click here to read the full Kraig Labs analyst report on 247marketnews.com.

Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by one or more featured companies for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/kblb-disclosure/ for further KBLB and 247marketnews.com disclosure information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (KBLB, BNBX, DNUT, BURU, IBIO, INVO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.